Abstract 5655: YL252: A dual-functional PD-L1/VEGF-targeting ADC integrating immunotherapy, anti-angiogenesis, and cytotoxicity.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Wei Lian, Xinzhen Shi, Qing Zong, Hanwen Deng, Chun Deng, Tao Wang, Fang Xu, Shuaikun Wang, Tongtong Xue, Jiaqiang Cai
Institution: MediLink Therapeutics (Suzhou) Co., Ltd. (China)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148726702
Cites:
Cited by:
Related to: